Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Neurol Neurosurg Psychiatry. 1998 Jun; 64(6): 730–735.
PMCID: PMC2170112

High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition


OBJECTIVE—To determine the incidence and prevalence of multiple sclerosis in the Lothian and Border Health Board Regions of south east Scotland.
METHODS—Incidence study: all patients were identified in whom a diagnosis of Poser category probable or definite multiple sclerosis was made by a neurologist between 1992 and 1995. Prevalence study: all patients known to have multiple sclerosis who were alive and resident in the study area on 15 March 1995 were recorded.
RESULTS—The crude annual incidence rates of probable or definite multiple sclerosis per 100 000 population were the highest ever reported: 12.2 (95% confidence interval (95% CI) 10.8-13.7) in the Lothian Region and 10.1 (95% CI 6.6-13.6) in the Border Region. A total of 1613 patients with multiple sclerosis were resident in the study area, giving standardised prevalence rates per 100 000 population of 203 (95% CI 192-214) in the Lothian Region and 219 (95% CI 191-251) in the Border Region. Prevalent cases were more likely than expected to have a Scottish surname (risk ratio 1.24, 95% CI 1.14-1.34).
CONCLUSIONS—Orkney and Shetland were previously thought to have by far the highest prevalence of multiple sclerosis in the world: about double that found in England and Wales. However, the prevalence in south east Scotland is equally high, suggesting that the Scottish population as a whole has a genetic susceptibility to the disease, and undermining the hypothesis that patterns of infection specific to small sparsely populated island communities are important in the causation of multiple sclerosis.

Full Text

The Full Text of this article is available as a PDF (105K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ebers GC, Sadovnick AD. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology. 1993;12(1):1–5. [PubMed]
  • Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev. 1993 Oct;6(4):382–427. [PMC free article] [PubMed]
  • Skegg DC, Corwin PA, Craven RS, Malloch JA, Pollock M. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry. 1987 Feb;50(2):134–139. [PMC free article] [PubMed]
  • Hammond SR, McLeod JG, Millingen KS, Stewart-Wynne EG, English D, Holland JT, McCall MG. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain. 1988 Feb;111(Pt 1):1–25. [PubMed]
  • Swingler RJ, Compston D. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1115–1124. [PMC free article] [PubMed]
  • SUTHERLAND JM. Observations on the prevalence of multiple sclerosis in Northern Scotland. Brain. 1956 Dec;79(4):635–654. [PubMed]
  • Fog M, Hyllested K. Prevalence of disseminated sclerosis in the Faroes, the Orkneys and Shetland. Acta Neurol Scand. 1966;42(Suppl):9–11. [PubMed]
  • Poskanzer DC, Prenney LB, Sheridan JL, Kondy JY. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology. J Epidemiol Community Health. 1980 Dec;34(4):229–239. [PMC free article] [PubMed]
  • Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS. Neurology. 1986 Mar;36(3):307–328. [PubMed]
  • Rice-Oxley M, Williams ES, Rees JE. A prevalence survey of multiple sclerosis in Sussex. J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):27–30. [PMC free article] [PubMed]
  • Shepherd DI, Summers A. Prevalence of multiple sclerosis in Rochdale. J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):415–417. [PMC free article] [PubMed]
  • Williams ES, McKeran RO. Prevalence of multiple sclerosis in a south London borough. Br Med J (Clin Res Ed) 1986 Jul 26;293(6541):237–239. [PMC free article] [PubMed]
  • Mumford CJ, Fraser MB, Wood NW, Compston DA. Multiple sclerosis in the Cambridge health district of east Anglia. J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):877–882. [PMC free article] [PubMed]
  • Roberts MH, Martin JP, McLellan DL, McIntosh-Michaelis SA, Spackman AJ. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority. J Neurol Neurosurg Psychiatry. 1991 Jan;54(1):55–59. [PMC free article] [PubMed]
  • Swingler RJ, Compston DA. The prevalence of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1520–1524. [PMC free article] [PubMed]
  • Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):2–6. [PMC free article] [PubMed]
  • Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. [PubMed]
  • Shepherd DI, Downie AW. A further prevalence study of multiple sclerosis in north-east Scotland. J Neurol Neurosurg Psychiatry. 1980 Apr;43(4):310–315. [PMC free article] [PubMed]
  • Miller DH, Hammond SR, McLeod JG, Purdie G, Skegg DC. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):903–905. [PMC free article] [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Group


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...